Nocardial brain abscess: observation of treatment strategies and outcome in Switzerland from 1992 to 1999
Options
BORIS DOI
Date of Publication
December 2001
Publication Type
Article
Division/Institute
Contributor
Loeffler, Jutta M. | |
Zimmerli, Werner |
Series
Infection
ISSN or ISBN (if monograph)
0300-8126
Publisher
Springer-Medizin-Verlag
Language
English
Publisher DOI
PubMed ID
11787836
Uncontrolled Keywords
Description
BACKGROUND
Brain abscesses caused by Nocardia spp. are rare, but life-threatening infections that are notoriously difficult to diagnose and treat and which occur mainly in immunocompromised patients. Standard treatment guidelines are not available.
METHODS
A systematic search for nocardial brain abscesses from 1992 to 1999 was conducted in Switzerland for the comparison of clinical presentation, treatment strategies and outcome.
RESULTS
Seven cases were found, for which data of six were available. In 4/6 patients antimicrobial therapy led to a decrease in the size of abscesses. Four of six patients died. The cause of death was likely due to underlying co-morbidities, rather than the nocardial infection.
CONCLUSION
The finding that treatment was different in each case underscores the lack of therapeutic guidelines.
Brain abscesses caused by Nocardia spp. are rare, but life-threatening infections that are notoriously difficult to diagnose and treat and which occur mainly in immunocompromised patients. Standard treatment guidelines are not available.
METHODS
A systematic search for nocardial brain abscesses from 1992 to 1999 was conducted in Switzerland for the comparison of clinical presentation, treatment strategies and outcome.
RESULTS
Seven cases were found, for which data of six were available. In 4/6 patients antimicrobial therapy led to a decrease in the size of abscesses. Four of six patients died. The cause of death was likely due to underlying co-morbidities, rather than the nocardial infection.
CONCLUSION
The finding that treatment was different in each case underscores the lack of therapeutic guidelines.
File(s)
| File | File Type | Format | Size | License | Publisher/Copright statement | Content | |
|---|---|---|---|---|---|---|---|
| art%3A10.1007%2Fs15010-001-1147-1.pdf | text | Adobe PDF | 93.38 KB | published |